{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:51:05Z","timestamp":1785149465301,"version":"3.55.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35 GM151879"],"award-info":[{"award-number":["R35 GM151879"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004343","name":"Stavros Niarchos Foundation","doi-asserted-by":"publisher","award":["SNF RU Institute for Global Infectious Disease Research at The Rockefeller University"],"award-info":[{"award-number":["SNF RU Institute for Global Infectious Disease Research at The Rockefeller University"]}],"id":[{"id":"10.13039\/501100004343","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004343","name":"Stavros Niarchos Foundation","doi-asserted-by":"publisher","award":["SNF RU Institute for Global Infectious Disease Research at The Rockefeller University"],"award-info":[{"award-number":["SNF RU Institute for Global Infectious Disease Research at The Rockefeller University"]}],"id":[{"id":"10.13039\/501100004343","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004343","name":"Stavros Niarchos Foundation","doi-asserted-by":"publisher","award":["SNF RU Institute for Global Infectious Disease Research at The Rockefeller University"],"award-info":[{"award-number":["SNF RU Institute for Global Infectious Disease Research at The Rockefeller University"]}],"id":[{"id":"10.13039\/501100004343","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["# UL1 TR001866"],"award-info":[{"award-number":["# UL1 TR001866"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["NIH T32 GM136640-Tan"],"award-info":[{"award-number":["NIH T32 GM136640-Tan"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["U19AI162584"],"award-info":[{"award-number":["U19AI162584"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["432291016"],"award-info":[{"award-number":["432291016"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Microbiol"],"DOI":"10.1038\/s41564-025-02201-6","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T10:01:47Z","timestamp":1764756107000},"page":"180-194","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Transcription co-inhibition alters drug resistance evolution and enhances Mycobacterium tuberculosis clearance from granulomas"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7708-6461","authenticated-orcid":false,"given":"Barbara","family":"Bosch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0925-9632","authenticated-orcid":false,"given":"Vanisha","family":"Munsamy-Govender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1532-146X","authenticated-orcid":false,"given":"Jansy","family":"Sarathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2669-3998","authenticated-orcid":false,"given":"Mirjana","family":"Lilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3429-6618","authenticated-orcid":false,"given":"Paul Dominic B.","family":"Olinares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn A.","family":"Eckartt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1268-2290","authenticated-orcid":false,"given":"Pranav","family":"Nalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7006-6861","authenticated-orcid":false,"given":"Marcell","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0062-7896","authenticated-orcid":false,"given":"Adrian","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9310-951X","authenticated-orcid":false,"given":"Jeremy M.","family":"Rock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1332-128X","authenticated-orcid":false,"given":"Elizabeth A.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"2201_CR1","unstructured":"Global Tuberculosis Report (WHO, 2024)."},{"key":"2201_CR2","unstructured":"Clinical Overview of Latent Tuberculosis Infection (CDC, 2024)."},{"key":"2201_CR3","doi-asserted-by":"publisher","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","volume":"13","author":"RMGJ Houben","year":"2016","unstructured":"Houben, R. M. G. J. & Dodd, P. J. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med. 13, e1002152 (2016).","journal-title":"PLoS Med."},{"key":"2201_CR4","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1016\/j.ajpath.2018.04.006","volume":"188","author":"EA Ihms","year":"2018","unstructured":"Ihms, E. A., Urbanowski, M. E. & Bishai, W. R. Diverse cavity types and evidence that mechanical action on the necrotic granuloma drives tuberculous cavitation. Am. J. Pathol. 188, 1666\u20131675 (2018).","journal-title":"Am. J. Pathol."},{"key":"2201_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.7861\/clinmedicine.12-1-40","volume":"12","author":"W Saeed","year":"2012","unstructured":"Saeed, W. Cavitating pulmonary tuberculosis: a global challenge. Clin. Med. Lond. Engl. 12, 40\u201341 (2012).","journal-title":"Clin. Med. Lond. Engl."},{"key":"2201_CR6","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1016\/S1473-3099(20)30148-1","volume":"20","author":"ME Urbanowski","year":"2020","unstructured":"Urbanowski, M. E., Ordonez, A. A., Ruiz-Bedoya, C. A., Jain, S. K. & Bishai, W. R. Cavitary tuberculosis: the gateway of disease transmission. Lancet Infect. Dis. 20, e117\u2013e128 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"2201_CR7","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S1473-3099(17)30233-5","volume":"17","author":"MW Pletz","year":"2017","unstructured":"Pletz, M. W., Hagel, S. & Forstner, C. Who benefits from antimicrobial combination therapy? Lancet Infect. Dis. 17, 677\u2013678 (2017).","journal-title":"Lancet Infect. Dis."},{"key":"2201_CR8","doi-asserted-by":"crossref","unstructured":"Sarathy, J. P. et al. Extreme drug tolerance of Mycobacterium tuberculosis in caseum. Antimicrob. Agents Chemother. 62, e02266-17 (2018).","DOI":"10.1128\/AAC.02266-17"},{"key":"2201_CR9","unstructured":"Latent Tuberculosis Infection: Updated and Consolidated Guidelines for Programmatic Management (WHO, 2018)."},{"key":"2201_CR10","unstructured":"Treatment Regimens for Latent TB Infection (CDC, 2025)."},{"key":"2201_CR11","doi-asserted-by":"publisher","first-page":"ofab018","DOI":"10.1093\/ofid\/ofab018","volume":"8","author":"JH Malenfant","year":"2021","unstructured":"Malenfant, J. H. & Brewer, T. F. Rifampicin mono-resistant tuberculosis\u2014a review of an uncommon but growing challenge for global tuberculosis control. Open Forum Infect. Dis. 8, ofab018 (2021).","journal-title":"Open Forum Infect. Dis."},{"key":"2201_CR12","doi-asserted-by":"crossref","unstructured":"Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet Lond. Engl. 399, 629\u2013655 (2022).","DOI":"10.1016\/S0140-6736(21)02724-0"},{"key":"2201_CR13","doi-asserted-by":"publisher","unstructured":"Eckartt, K. A. et al. Compensatory evolution in NusG improves fitness of drug-resistant M. tuberculosis. Nature https:\/\/doi.org\/10.1038\/s41586-024-07206-5 (2024).","DOI":"10.1038\/s41586-024-07206-5"},{"key":"2201_CR14","doi-asserted-by":"publisher","first-page":"e00164","DOI":"10.1128\/AAC.00164-18","volume":"62","author":"MA Stefan","year":"2018","unstructured":"Stefan, M. A., Ugur, F. S. & Garcia, G. A. Source of the fitness defect in rifamycin-resistant Mycobacterium tuberculosis RNA polymerase and the mechanism of compensation by mutations in the \u03b2\u2019 subunit. Antimicrob. Agents Chemother. 62, e00164-18 (2018).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2201_CR15","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S0092-8674(01)00286-0","volume":"104","author":"EA Campbell","year":"2001","unstructured":"Campbell, E. A. et al. Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell 104, 901\u2013912 (2001).","journal-title":"Cell"},{"key":"2201_CR16","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1126\/science.1124410","volume":"312","author":"S Gagneux","year":"2006","unstructured":"Gagneux, S. et al. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 312, 1944\u20131946 (2006).","journal-title":"Science"},{"key":"2201_CR17","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/S2213-2600(23)00426-5","volume":"12","author":"SM Labuda","year":"2024","unstructured":"Labuda, S. M., Seaworth, B., Dasgupta, S. & Goswami, N. D. Bedaquiline, pretomanid, and linezolid with or without moxifloxacin for tuberculosis. Lancet Respir. Med. 12, e5\u2013e6 (2024).","journal-title":"Lancet Respir. Med."},{"key":"2201_CR18","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/S1473-3099(22)00543-6","volume":"22","author":"A Van Rie","year":"2022","unstructured":"Van Rie, A. et al. Balancing access to BPaLM regimens and risk of resistance. Lancet Infect. Dis. 22, 1411\u20131412 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"2201_CR19","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.1016\/j.cell.2021.06.033","volume":"184","author":"B Bosch","year":"2021","unstructured":"Bosch, B. et al. Genome-wide gene expression tuning reveals diverse vulnerabilities of M. tuberculosis. Cell 184, 4579\u20134592.e24 (2021).","journal-title":"Cell"},{"key":"2201_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41579-020-00450-2","volume":"19","author":"J Chen","year":"2021","unstructured":"Chen, J., Boyaci, H. & Campbell, E. A. Diverse and unified mechanisms of transcription initiation in bacteria. Nat. Rev. Microbiol. 19, 95\u2013109 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"2201_CR21","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.molcel.2023.04.007","volume":"83","author":"M Delbeau","year":"2023","unstructured":"Delbeau, M. et al. Structural and functional basis of the universal transcription factor NusG pro-pausing activity in Mycobacterium tuberculosis. Mol. Cell 83, 1474\u20131488.e8 (2023).","journal-title":"Mol. Cell"},{"key":"2201_CR22","doi-asserted-by":"publisher","first-page":"e2303849120","DOI":"10.1073\/pnas.2303849120","volume":"120","author":"K Inlow","year":"2023","unstructured":"Inlow, K., Tenenbaum, D., Friedman, L. J., Kondev, J. & Gelles, J. Recycling of bacterial RNA polymerase by the Swi2\/Snf2 ATPase RapA. Proc. Natl Acad. Sci. USA 120, e2303849120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2201_CR23","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.cell.2018.05.017","volume":"173","author":"JY Kang","year":"2018","unstructured":"Kang, J. Y. et al. Structural basis for transcript elongation control by NusG family universal regulators. Cell 173, 1650\u20131662.e14 (2018).","journal-title":"Cell"},{"key":"2201_CR24","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1016\/j.jmb.2019.07.017","volume":"431","author":"JY Kang","year":"2019","unstructured":"Kang, J. Y., Mishanina, T. V., Landick, R. & Darst, S. A. Mechanisms of transcriptional pausing in bacteria. J. Mol. Biol. 431, 4007\u20134029 (2019).","journal-title":"J. Mol. Biol."},{"key":"2201_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev-micro-051721-043826","volume":"75","author":"R Landick","year":"2021","unstructured":"Landick, R. Transcriptional pausing as a mediator of bacterial gene regulation. Annu. Rev. Microbiol. 75, 291\u2013314 (2021).","journal-title":"Annu. Rev. Microbiol."},{"key":"2201_CR26","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1073\/pnas.88.6.2307","volume":"88","author":"PH von Hippel","year":"1991","unstructured":"von Hippel, P. H. & Yager, T. D. Transcript elongation and termination are competitive kinetic processes. Proc. Natl Acad. Sci. USA 88, 2307\u20132311 (1991).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2201_CR27","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34823","volume":"7","author":"H Boyaci","year":"2018","unstructured":"Boyaci, H. et al. Fidaxomicin jams Mycobacterium tuberculosis RNA polymerase motions needed for initiation via RbpA contacts. eLife 7, e34823 (2018).","journal-title":"eLife"},{"key":"2201_CR28","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41586-022-04545-z","volume":"604","author":"X Cao","year":"2022","unstructured":"Cao, X. et al. Basis of narrow-spectrum activity of fidaxomicin on Clostridioides difficile. Nature 604, 541\u2013545 (2022).","journal-title":"Nature"},{"key":"2201_CR29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.molcel.2018.02.026","volume":"70","author":"W Lin","year":"2018","unstructured":"Lin, W. et al. Structural basis of transcription inhibition by fidaxomicin (Lipiarmycin A3). Mol. Cell 70, 60\u201371.e15 (2018).","journal-title":"Mol. Cell"},{"key":"2201_CR30","doi-asserted-by":"publisher","first-page":"8949","DOI":"10.1016\/S0021-9258(17)34269-2","volume":"253","author":"WR McClure","year":"1978","unstructured":"McClure, W. R. & Cech, C. L. On the mechanism of rifampicin inhibition of RNA synthesis. J. Biol. Chem. 253, 8949\u20138956 (1978).","journal-title":"J. Biol. Chem."},{"key":"2201_CR31","doi-asserted-by":"publisher","first-page":"5079","DOI":"10.1021\/acs.jmedchem.3c00009","volume":"66","author":"M Lang","year":"2023","unstructured":"Lang, M. et al. Synthesis and characterization of phenylalanine amides active against Mycobacterium abscessus and other mycobacteria. J. Med. Chem. 66, 5079\u20135098 (2023).","journal-title":"J. Med. Chem."},{"key":"2201_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202300593","volume":"19","author":"M Lang","year":"2024","unstructured":"Lang, M. et al. Synthesis and in vitro metabolic stability of sterically shielded antimycobacterial phenylalanine amides. ChemMedChem 19, e202300593 (2024).","journal-title":"ChemMedChem"},{"key":"2201_CR33","doi-asserted-by":"publisher","first-page":"e202400267","DOI":"10.1002\/cbdv.202400267","volume":"21","author":"RW Seidel","year":"2024","unstructured":"Seidel, R. W., Goddard, R., Lang, M. & Richter, A. N\u03b1-aroyl-N-aryl-phenylalanine amides: a promising class of antimycobacterial agents targeting the RNA polymerase. Chem. Biodivers. 21, e202400267 (2024).","journal-title":"Chem. Biodivers."},{"key":"2201_CR34","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/cmdc.201200428","volume":"8","author":"L Ballell","year":"2013","unstructured":"Ballell, L. et al. Fueling open-source drug discovery: 177 small-molecule leads against tuberculosis. ChemMedChem 8, 313\u2013321 (2013).","journal-title":"ChemMedChem"},{"key":"2201_CR35","doi-asserted-by":"crossref","unstructured":"Lang, M., Ganapathy, U. S., Abdelaziz, R., Dick, T. & Richter, A. Broad-spectrum in vitro activity of N\u03b1-aroyl-N-aryl-phenylalanine amides against non-tuberculous mycobacteria and comparative analysis of RNA polymerases. Antibiotics 13, 404 (2024).","DOI":"10.3390\/antibiotics13050404"},{"key":"2201_CR36","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.molcel.2017.03.001","volume":"66","author":"W Lin","year":"2017","unstructured":"Lin, W. et al. Structural basis of Mycobacterium tuberculosis transcription and transcription inhibition. Mol. Cell 66, 169\u2013179.e8 (2017).","journal-title":"Mol. Cell"},{"key":"2201_CR37","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1126\/science.1087526","volume":"302","author":"I Artsimovitch","year":"2003","unstructured":"Artsimovitch, I., Chu, C., Lynch, A. S. & Landick, R. A new class of bacterial RNA polymerase inhibitor affects nucleotide addition. Science 302, 650\u2013654 (2003).","journal-title":"Science"},{"key":"2201_CR38","doi-asserted-by":"publisher","first-page":"E4178","DOI":"10.1073\/pnas.1502368112","volume":"112","author":"B Bae","year":"2015","unstructured":"Bae, B. et al. CBR antimicrobials inhibit RNA polymerase via at least two bridge-helix cap-mediated effects on nucleotide addition. Proc. Natl Acad. Sci. USA 112, E4178\u2013E4187 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2201_CR39","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.str.2015.06.009","volume":"23","author":"Y Feng","year":"2015","unstructured":"Feng, Y. et al. Structural basis of transcription inhibition by CBR hydroxamidines and CBR pyrazoles. Structure 23, 1470\u20131481 (2015).","journal-title":"Structure"},{"key":"2201_CR40","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.str.2020.11.001","volume":"29","author":"PDB Olinares","year":"2021","unstructured":"Olinares, P. D. B. et al. Native mass spectrometry-based screening for optimal sample preparation in single-particle cryo-EM. Structure 29, 186\u2013195.e6 (2021).","journal-title":"Structure"},{"key":"2201_CR41","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02760-22","volume":"10","author":"L Mann","year":"2022","unstructured":"Mann, L. et al. In vitro profiling of the synthetic RNA polymerase inhibitor MMV688845 against Mycobacterium abscessus. Microbiol. Spectr. 10, e0276022 (2022).","journal-title":"Microbiol. Spectr."},{"key":"2201_CR42","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1016\/j.jmb.2019.05.042","volume":"431","author":"GA Belogurov","year":"2019","unstructured":"Belogurov, G. A. & Artsimovitch, I. The mechanisms of substrate selection, catalysis, and translocation by the elongating RNA polymerase. J. Mol. Biol. 431, 3975\u20134006 (2019).","journal-title":"J. Mol. Biol."},{"key":"2201_CR43","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1126\/science.1059495","volume":"292","author":"AL Gnatt","year":"2001","unstructured":"Gnatt, A. L., Cramer, P., Fu, J., Bushnell, D. A. & Kornberg, R. D. Structural basis of transcription: an RNA polymerase II elongation complex at 3.3\u2009\u00c5 resolution. Science 292, 1876\u20131882 (2001).","journal-title":"Science"},{"key":"2201_CR44","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1126\/science.289.5479.619","volume":"289","author":"N Korzheva","year":"2000","unstructured":"Korzheva, N. et al. A structural model of transcription elongation. Science 289, 619\u2013625 (2000).","journal-title":"Science"},{"key":"2201_CR45","doi-asserted-by":"crossref","unstructured":"Zhang, J. & Landick, R. in RNA Polymerases as Molecular Motors (eds Buc, H. & Strick, T.) 206\u2013235 (The Royal Society of Chemistry, 2009).","DOI":"10.1039\/9781847559982-00206"},{"key":"2201_CR46","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkad761","volume":"51","author":"D Jensen","year":"2023","unstructured":"Jensen, D. et al. High-throughput, fluorescent-aptamer-based measurements of steady-state transcription rates for the Mycobacterium tuberculosis RNA polymerase. Nucleic Acids Res. 51, e99 (2023).","journal-title":"Nucleic Acids Res."},{"key":"2201_CR47","doi-asserted-by":"publisher","first-page":"14469","DOI":"10.1074\/jbc.M110.212902","volume":"286","author":"M Jovanovic","year":"2011","unstructured":"Jovanovic, M. et al. Activity map of the Escherichia coli RNA polymerase bridge helix. J. Biol. Chem. 286, 14469\u201314479 (2011).","journal-title":"J. Biol. Chem."},{"key":"2201_CR48","doi-asserted-by":"publisher","first-page":"6079","DOI":"10.1073\/pnas.1011274108","volume":"108","author":"SR Kennedy","year":"2011","unstructured":"Kennedy, S. R. & Erie, D. A. Templated nucleoside triphosphate binding to a noncatalytic site on RNA polymerase regulates transcription. Proc. Natl Acad. Sci. USA 108, 6079\u20136084 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2201_CR49","doi-asserted-by":"publisher","first-page":"18942","DOI":"10.1073\/pnas.0905402106","volume":"106","author":"N Miropolskaya","year":"2009","unstructured":"Miropolskaya, N., Artsimovitch, I., Klimasauskas, S., Nikiforov, V. & Kulbachinskiy, A. Allosteric control of catalysis by the F loop of RNA polymerase. Proc. Natl Acad. Sci. USA 106, 18942\u201318947 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2201_CR50","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4161\/trns.1.2.12544","volume":"1","author":"N Miropolskaya","year":"2010","unstructured":"Miropolskaya, N., Nikiforov, V., Klimasauskas, S., Artsimovitch, I. & Kulbachinskiy, A. Modulation of RNA polymerase activity through the trigger loop folding. Transcription 1, 89\u201394 (2010).","journal-title":"Transcription"},{"key":"2201_CR51","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1093\/nar\/gkt877","volume":"42","author":"N Miropolskaya","year":"2014","unstructured":"Miropolskaya, N. et al. Interplay between the trigger loop and the F loop during RNA polymerase catalysis. Nucleic Acids Res. 42, 544\u2013552 (2014).","journal-title":"Nucleic Acids Res."},{"key":"2201_CR52","doi-asserted-by":"publisher","first-page":"e0214088","DOI":"10.1371\/journal.pone.0214088","volume":"14","author":"S Borrell","year":"2019","unstructured":"Borrell, S. et al. Reference set of Mycobacterium tuberculosis clinical strains: a tool for research and product development. PLoS ONE 14, e0214088 (2019).","journal-title":"PLoS ONE"},{"key":"2201_CR53","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1128\/AAC.48.4.1289-1294.2004","volume":"48","author":"DH Mariam","year":"2004","unstructured":"Mariam, D. H., Mengistu, Y., Hoffner, S. E. & Andersson, D. I. Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 48, 1289\u20131294 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2201_CR54","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1128\/AAC.46.5.1204-1211.2002","volume":"46","author":"P Sander","year":"2002","unstructured":"Sander, P. et al. Fitness cost of chromosomal drug resistance-conferring mutations. Antimicrob. Agents Chemother. 46, 1204\u20131211 (2002).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2201_CR55","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0022-2836(88)90455-X","volume":"202","author":"DJ Jin","year":"1988","unstructured":"Jin, D. J., Walter, W. A. & Gross, C. A. Characterization of the termination phenotypes of rifampicin-resistant mutants. J. Mol. Biol. 202, 245\u2013253 (1988).","journal-title":"J. Mol. Biol."},{"key":"2201_CR56","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1128\/AAC.33.9.1493","volume":"33","author":"K Takayama","year":"1989","unstructured":"Takayama, K. & Kilburn, J. O. Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 33, 1493\u20131499 (1989).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2201_CR57","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/genetics\/28.6.491","volume":"28","author":"SE Luria","year":"1943","unstructured":"Luria, S. E. & Delbr\u00fcck, M. Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28, 491\u2013511 (1943).","journal-title":"Genetics"},{"key":"2201_CR58","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00598-23","volume":"14","author":"JP Sarathy","year":"2023","unstructured":"Sarathy, J. P. et al. A novel tool to identify bactericidal compounds against vulnerable targets in drug-tolerant M. tuberculosis found in caseum. mBio 14, e0059823 (2023).","journal-title":"mBio"},{"key":"2201_CR59","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1021\/acsinfecdis.4c00499","volume":"10","author":"P Ashwath","year":"2024","unstructured":"Ashwath, P., Osiecki, P., Weiner, D., Via, L. E. & Sarathy, J. P. Role of DNA double-strand break formation in gyrase inhibitor-mediated killing of nonreplicating persistent Mycobacterium tuberculosis in caseum. ACS Infect. Dis. 10, 3631\u20133639 (2024).","journal-title":"ACS Infect. Dis."},{"key":"2201_CR60","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1128\/br.20.4.243-258.1956","volume":"20","author":"CI Bliss","year":"1956","unstructured":"Bliss, C. I. The calculation of microbial assays. Bacteriol. Rev. 20, 243\u2013258 (1956).","journal-title":"Bacteriol. Rev."},{"key":"2201_CR61","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1038\/s41598-024-52814-w","volume":"14","author":"T Abd El-Hafeez","year":"2024","unstructured":"Abd El-Hafeez, T., Shams, M. Y., Elshaier, Y. A. M. M., Farghaly, H.M. & Hassanien, A. E. Harnessing machine learning to find synergistic combinations for FDA-approved cancer drugs. Sci. Rep. 14, 2428 (2024).","journal-title":"Sci. Rep."},{"key":"2201_CR62","doi-asserted-by":"publisher","first-page":"aad3292","DOI":"10.1126\/science.aad3292","volume":"351","author":"M Baym","year":"2016","unstructured":"Baym, M., Stone, L. K. & Kishony, R. Multidrug evolutionary strategies to reverse antibiotic resistance. Science 351, aad3292 (2016).","journal-title":"Science"},{"key":"2201_CR63","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/s41564-021-00973-1","volume":"6","author":"A Rasouly","year":"2021","unstructured":"Rasouly, A. et al. Analysing the fitness cost of antibiotic resistance to identify targets for combination antimicrobials. Nat. Microbiol. 6, 1410\u20131423 (2021).","journal-title":"Nat. Microbiol."},{"key":"2201_CR64","doi-asserted-by":"publisher","first-page":"e1009172","DOI":"10.1371\/journal.ppat.1009172","volume":"17","author":"R Roemhild","year":"2021","unstructured":"Roemhild, R. & Andersson, D. I. Mechanisms and therapeutic potential of collateral sensitivity to antibiotics. PLoS Pathog. 17, e1009172 (2021).","journal-title":"PLoS Pathog."},{"key":"2201_CR65","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1128\/jb.64.4.489-499.1952","volume":"64","author":"W Szybalski","year":"1952","unstructured":"Szybalski, W. & Bryson, V. Genetic studies on microbial cross resistance to toxic agents. I. Cross resistance of Escherichia coli to fifteen antibiotics. J. Bacteriol. 64, 489\u2013499 (1952).","journal-title":"J. Bacteriol."},{"key":"2201_CR66","unstructured":"Xpert MTB\/RIF Assay (CDC, 2024)."},{"key":"2201_CR67","unstructured":"Molecular Detection of Drug Resistance (MDDR) in Mycobacterium tuberculosis Complex by DNA Sequencing User Guide (CDC, 2024)."},{"key":"2201_CR68","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s40164-024-00568-6","volume":"13","author":"K Kupcova","year":"2024","unstructured":"Kupcova, K. et al. Vertical targeting of the PI3K\/AKT pathway at multiple points is synergistic and effective for non-Hodgkin lymphoma. Exp. Hematol. Oncol. 13, 108 (2024).","journal-title":"Exp. Hematol. Oncol."},{"key":"2201_CR69","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1158\/1078-0432.CCR-19-3523","volume":"26","author":"MB Ryan","year":"2020","unstructured":"Ryan, M. B. et al. Vertical Pathway inhibition overcomes adaptive feedback resistance to KRASG12C inhibition. Clin. Cancer Res. 26, 1633\u20131643 (2020).","journal-title":"Clin. Cancer Res."},{"key":"2201_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2017.86","volume":"6","author":"S-U Woo","year":"2017","unstructured":"Woo, S.-U. et al. Vertical inhibition of the PI3K\/Akt\/mTOR pathway is synergistic in breast cancer. Oncogenesis 6, e385 (2017).","journal-title":"Oncogenesis"},{"key":"2201_CR71","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1002\/1878-0261.13510","volume":"17","author":"TM Reissig","year":"2023","unstructured":"Reissig, T. M. et al. Lasting response by vertical inhibition with cetuximab and trametinib in KRAS-mutated colorectal cancer patient-derived xenografts. Mol. Oncol. 17, 2396\u20132414 (2023).","journal-title":"Mol. Oncol."},{"key":"2201_CR72","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1001\/archinte.163.4.402","volume":"163","author":"PA Masters","year":"2003","unstructured":"Masters, P. A., O\u2019Bryan, T. A., Zurlo, J., Miller, D. Q. & Joshi, N. Trimethoprim-sulfamethoxazole revisited. Arch. Intern. Med. 163, 402\u2013410 (2003).","journal-title":"Arch. Intern. Med."},{"key":"2201_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03447-x","volume":"9","author":"Y Minato","year":"2018","unstructured":"Minato, Y. et al. Mutual potentiation drives synergy between trimethoprim and sulfamethoxazole. Nat. Commun. 9, 1003 (2018).","journal-title":"Nat. Commun."},{"key":"2201_CR74","doi-asserted-by":"publisher","first-page":"5269","DOI":"10.1128\/AAC.03389-14","volume":"58","author":"J Noeske","year":"2014","unstructured":"Noeske, J. et al. Synergy of streptogramin antibiotics occurs independently of their effects on translation. Antimicrob. Agents Chemother. 58, 5269\u20135279 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2201_CR75","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41579-022-00731-y","volume":"20","author":"VA Dartois","year":"2022","unstructured":"Dartois, V. A. & Rubin, E. J. Anti-tuberculosis treatment strategies and drug development: challenges and priorities. Nat. Rev. Microbiol. 20, 685\u2013701 (2022).","journal-title":"Nat. Rev. Microbiol."},{"key":"2201_CR76","doi-asserted-by":"publisher","first-page":"7171","DOI":"10.1073\/pnas.1504942112","volume":"112","author":"EA Hubin","year":"2015","unstructured":"Hubin, E. A. et al. Structural, functional, and genetic analyses of the actinobacterial transcription factor RbpA. Proc. Natl Acad. Sci. USA 112, 7171\u20137176 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2201_CR77","doi-asserted-by":"publisher","first-page":"12619","DOI":"10.1073\/pnas.1308270110","volume":"110","author":"DB Srivastava","year":"2013","unstructured":"Srivastava, D. B. et al. Structure and function of CarD, an essential mycobacterial transcription factor. Proc. Natl Acad. Sci. USA 110, 12619\u201312624 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2201_CR78","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/nar\/gku1231","volume":"43","author":"E Davis","year":"2015","unstructured":"Davis, E., Chen, J., Leon, K., Darst, S. A. & Campbell, E. A. Mycobacterial RNA polymerase forms unstable open promoter complexes that are stabilized by CarD. Nucleic Acids Res. 43, 433\u2013445 (2015).","journal-title":"Nucleic Acids Res."},{"key":"2201_CR79","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/978-1-4939-9822-7_17","volume":"2062","author":"PDB Olinares","year":"2020","unstructured":"Olinares, P. D. B. & Chait, B. T. Native mass spectrometry analysis of affinity-captured endogenous yeast RNA exosome complexes. Methods Mol. Biol. 2062, 357\u2013382 (2020).","journal-title":"Methods Mol. Biol."},{"key":"2201_CR80","doi-asserted-by":"publisher","first-page":"4370","DOI":"10.1021\/acs.analchem.5b00140","volume":"87","author":"MT Marty","year":"2015","unstructured":"Marty, M. T. et al. Bayesian deconvolution of mass and ion mobility spectra: from binary interactions to polydisperse ensembles. Anal. Chem. 87, 4370\u20134376 (2015).","journal-title":"Anal. Chem."},{"key":"2201_CR81","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s13361-018-1951-9","volume":"30","author":"DJ Reid","year":"2019","unstructured":"Reid, D. J. et al. MetaUniDec: high-throughput deconvolution of native mass spectra. J. Am. Soc. Mass. Spectrom. 30, 118\u2013127 (2019).","journal-title":"J. Am. Soc. Mass. Spectrom."},{"key":"2201_CR82","doi-asserted-by":"publisher","first-page":"e00931","DOI":"10.1128\/mBio.00931-14","volume":"5","author":"A Czyz","year":"2014","unstructured":"Czyz, A., Mooney, R. A., Iaconi, A. & Landick, R. Mycobacterial RNA polymerase requires a U-tract at intrinsic terminators and is aided by NusG at suboptimal terminators. mBio 5, e00931 (2014).","journal-title":"mBio"},{"key":"2201_CR83","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","volume":"152","author":"DN Mastronarde","year":"2005","unstructured":"Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36\u201351 (2005).","journal-title":"J. Struct. Biol."},{"key":"2201_CR84","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"2201_CR85","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"2201_CR86","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jsb.2012.09.006","volume":"180","author":"SHW Scheres","year":"2012","unstructured":"Scheres, S. H. W. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 180, 519\u2013530 (2012).","journal-title":"J. Struct. Biol."},{"key":"2201_CR87","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.42166","volume":"7","author":"J Zivanov","year":"2018","unstructured":"Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. eLife 7, e42166 (2018).","journal-title":"eLife"},{"key":"2201_CR88","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.pbiomolbio.2019.09.002","volume":"150","author":"PR Baldwin","year":"2020","unstructured":"Baldwin, P. R. & Lyumkis, D. Non-uniformity of projection distributions attenuates resolution in cryo-EM. Prog. Biophys. Mol. Biol. 150, 160\u2013183 (2020).","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"2201_CR89","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"2201_CR90","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"2201_CR91","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nmeth.4347","volume":"14","author":"YZ Tan","year":"2017","unstructured":"Tan, Y. Z. et al. Addressing preferred specimen orientation in single-particle cryo-EM through tilting. Nat. Methods 14, 793\u2013796 (2017).","journal-title":"Nat. Methods"},{"key":"2201_CR92","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.01456","volume":"2","author":"A Morin","year":"2013","unstructured":"Morin, A. et al. Collaboration gets the most out of software. eLife 2, e01456 (2013).","journal-title":"eLife"},{"key":"2201_CR93","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/protein\/8.2.127","volume":"8","author":"AC Wallace","year":"1995","unstructured":"Wallace, A. C., Laskowski, R. A. & Thornton, J. M. LIGPLOT: a program to generate schematic diagrams of protein\u2013ligand interactions. Protein Eng. 8, 127\u2013134 (1995).","journal-title":"Protein Eng."},{"key":"2201_CR94","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/ng.811","volume":"43","author":"CB Ford","year":"2011","unstructured":"Ford, C. B. et al. Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection. Nat. Genet. 43, 482\u2013486 (2011).","journal-title":"Nat. Genet."},{"key":"2201_CR95","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/ng.2656","volume":"45","author":"CB Ford","year":"2013","unstructured":"Ford, C. B. et al. Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis. Nat. Genet. 45, 784\u2013790 (2013).","journal-title":"Nat. Genet."},{"key":"2201_CR96","doi-asserted-by":"publisher","first-page":"e00314","DOI":"10.1128\/MRA.00314-21","volume":"10","author":"Q Zheng","year":"2021","unstructured":"Zheng, Q. webSalvador: a web tool for the Luria-Delbr\u00fck experiment. Microbiol. Resour. Announc. 10, e00314\u2013e00321 (2021).","journal-title":"Microbiol. Resour. Announc."},{"key":"2201_CR97","doi-asserted-by":"publisher","first-page":"110016","DOI":"10.1098\/rsob.110016","volume":"1","author":"S Subbian","year":"2011","unstructured":"Subbian, S. et al. Chronic pulmonary cavitary tuberculosis in rabbits: a failed host immune response. Open Biol. 1, 110016 (2011).","journal-title":"Open Biol."},{"key":"2201_CR98","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1128\/IAI.01515-07","volume":"76","author":"LE Via","year":"2008","unstructured":"Via, L. E. et al. Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect. Immun. 76, 2333\u20132340 (2008).","journal-title":"Infect. Immun."},{"key":"2201_CR99","doi-asserted-by":"publisher","unstructured":"Bosch, B. et al. Transcription co-inhibition reduces rifampicin resistance and enhances M. tuberculosis granuloma clearance, native mass spectrometry datasets. Figshare https:\/\/doi.org\/10.6084\/m9.figshare.30259192 (2025).","DOI":"10.6084\/m9.figshare.30259192"},{"key":"2201_CR100","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06587-2","volume":"9","author":"J Peek","year":"2018","unstructured":"Peek, J. et al. Rifamycin congeners kanglemycins are active against rifampicin-resistant bacteria via a distinct mechanism. Nat. Commun. 9, 4147 (2018).","journal-title":"Nat. Commun."},{"key":"2201_CR101","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/BF02986080","volume":"49","author":"DE Lea","year":"1949","unstructured":"Lea, D. E. & Coulson, C. A. The distribution of the numbers of mutants in bacterial populations. J. Genet. 49, 264\u2013285 (1949).","journal-title":"J. Genet."},{"key":"2201_CR102","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.gpb.2022.01.004","volume":"20","author":"S Zheng","year":"2022","unstructured":"Zheng, S. et al. SynergyFinder Plus: toward better interpretation and annotation of drug combination screening datasets. Genomics Proteomics Bioinformatics 20, 587\u2013596 (2022).","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"2201_CR103","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D Struct. Biol. 75, 861\u2013877 (2019).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"2201_CR104","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/pro.3293","volume":"27","author":"JB Heymann","year":"2018","unstructured":"Heymann, J. B. Guidelines for using Bsoft for high resolution reconstruction and validation of biomolecular structures from electron micrographs. Protein Sci. 27, 159\u2013171 (2018).","journal-title":"Protein Sci."},{"key":"2201_CR105","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jsb.2013.08.002","volume":"184","author":"G Cardone","year":"2013","unstructured":"Cardone, G., Heymann, J. B. & Steven, A. C. One number does not fit all: mapping local variations in resolution in cryo-EM reconstructions. J. Struct. Biol. 184, 226\u2013236 (2013).","journal-title":"J. Struct. Biol."}],"container-title":["Nature Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41564-025-02201-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-025-02201-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-025-02201-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T21:02:58Z","timestamp":1769806978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41564-025-02201-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["2201"],"URL":"https:\/\/doi.org\/10.1038\/s41564-025-02201-6","relation":{},"ISSN":["2058-5276"],"issn-type":[{"value":"2058-5276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"14 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}